GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of SELECT: what the trials say vs what this community says — 35 comments in the full submission. View in context.
1.1k
c/trialwatch·submitted 3 months ago by u/camila_vasquez

SELECT: what the trials say vs what this community says

Trial Databranch of 12 comments

The title is the argument: SELECT: what the trials say vs what this community says. Here is the rest of it. Intention-to-treat analyses everybody randomised regardless of what they did afterwards. Completer analyses only those who finished. The second is systematically more flattering and both are legitimate if…

Read the full submission and all 35 comments →

This branch

12 comments, started 3 months ago
u/hedda_adeyemi22 points·3 months ago

A confidence interval is the range of effects compatible with the data. Two trials with overlapping intervals have not disagreed, whatever their point estimates look like next to each other.

replysharereportpermalink
u/paper_trail_paulavetting6 points·3 months ago

How to read one of these papers in fifteen minutes, in the order that actually helps.

Start with the registered protocol and check the primary endpoint against what is reported. Then the methods: who was included, what the comparator was, how long the randomised phase ran. Then the discontinuation numbers, which are a tolerability result and are usually in a supplementary table.

Only then the efficacy figure, and read the interval rather than the point estimate. Finish with the limitations section, which is where the authors say what they actually think.

Fifteen minutes, and you will know more than any thread summarising it.

replysharereportpermalink
u/rina_bergstrom1 point·3 months ago

Spent an evening with the appendix tables and found the subgroup detail that the entire thread had been speculating about.

replysharereportpermalink
u/prior_auth_painappeals1 point·3 months ago

a mean is not a promise

replysharereportpermalink
u/camila_vasquezOP3 points·3 months ago

Went looking for the registered protocol to see whether the endpoint had changed. It had not, which was reassuring and worth checking.

replysharereportpermalink
u/kaia_cabrera2 points·3 months ago

That is a relative risk reduction. Quoting it without the absolute numbers overstates the case considerably.

replysharereportpermalink
u/gastric_emptying_g1 point·3 months ago

Relative risk reduction without the baseline rate is uninterpretable. A large relative reduction on a small absolute risk is a small absolute benefit.

replysharereportpermalink
u/eu_apotheke_a1 point·3 months ago

The press release said that; the publication says something more hedged. Worth reading both.

replysharereportpermalink
u/rulebook_rachaelmod · c/meta7 points·3 months ago

intention to treat versus completers changes the number substantially

replysharereportpermalink
u/sten_palacios4 points·3 months ago

Is that intention-to-treat or completers?

replysharereportpermalink
u/forest_plot_fionastats1 point·3 months ago

the confidence interval is the finding, the point estimate is the headline

replysharereportpermalink
u/camila_vasquezOP1 point·3 months ago·edited

What was the comparator?

replysharereportpermalink

← back to the whole thread

About c/trialwatch

Clinical trial reading group. New readouts, protocol amendments, endpoint definitions, dropout handling, and the difference between a press release and a publication. Absolute risk reduction and number-needed-to-treat are house dialect here.

34kmembers
95submissions
Nov 2023created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
c/trialwatch rules
  1. Press-release-only posts must be flaired Press Release until a publication exists.
  2. Give the trial name, phase, n, and primary endpoint in the body.
  3. Relative risk reduction alone is not a result. Show the absolute numbers.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.